baber/WOPTO huggingface dataset:
Patent AU-5633000-A (AU)
Title: Texturized cellulosic and lignocellulosic materials and compositions and composites made therefrom
Inventor: LAGACE ARTHUR
IPC: A23L1/308
Filed: 2000-06-22
Abstract: Texturized cellulosic or lignocellulosic materials (e.g., texturized polycoated paper), and compositions and composites made therefrom, are disclosed.
Patent AU-5760590-A (AU)
Title: Screening machine
IPC: B07B1/30
Filed: 1990-06-19
Abstract: In a screening machine comprising two screening frames (13 and 31) each having mutual oppositely located feed and discharge ends on which there is arranged an elastic screening lining (54) and which are caused to oscillate by independent oscillating drives wherein the two screening frames (13 and 31) are associated with each other at different heights in such a way that the lower region of the upper screening frame (31) and the upper region of the lower screening frame (13) lie in a common plane, that the elastic screening lining (54) is secured to the two screening frame (13, 31) in the common plane thereof and that the upper screening frame (31) is independently driven in a circular configuration at the feed end and the lower screening frame (13) is indepndently driven in a circular configuration at the discharge end.
Patent AU-5810100-A (AU)
Title: Drill bit having a replaceable cutting head
Inventor: KRENZER ULRICH
IPC: B23B51/02
Filed: 2000-05-27
Abstract: A twist drill, having a replaceable drill tip, comprising a drill bit shaft ( 1 ), a cutting insert ( 2 ) which is detachably fixed thereto and which forms the tip area of the twist drill, and comprises a flute ( 3 ) that continues into the cutting insert ( 2 ). The cutting insert rests, with a bearing surface ( 6 ) extending orthogonal to the center longitudinal axis ( 8 ) of the drill bit, on the face ( 7 ) of the drill bit shaft ( 1 ) and extends with a fixing stud ( 9 ), which centrally protrudes from the bearing surface ( 6 ), into a receiving recess ( 10 ) which is configured complementary thereto and which is provided in the face ( 7 ) of the drill bit shaft ( 1 ). At least one peripheral section ( 13 ) of the fixing stud ( 9 ) comprises a first longitudinal section ( 15 ) that, with a screw surface ( 16 ) which points away from the drill bit shaft ( 1 ), which slopes upward to the drill bit tip ( 5 ) in a direction of rotation of the drill bit, and which interacts with an opposite surface ( 19 ) on the inner wall ( 14 ) of the receiving recess ( 10 ), merges into a second longitudinal section ( 17 ).
Patent AU-5821396-A (AU)
Title: A method in a pneumatic oscillating device to observe an obs tacle and to continue oscillating and corresponding oscillat ing device
Inventor: JAUHOLA LAURI
IPC: F15B21/12
Filed: 1996-05-27
Abstract: PCT No. PCT/FI96/00299 Sec. 371 Date Nov. 28, 1997 Sec. 102(e) Date Nov. 28, 1997 PCT Filed Mar. 27, 1996 PCT Pub. No. WO96/38673 PCT Pub. Date Dec. 5, 1996The object of the invention is a method in a pneumatic oscillating device for observing an obstacle within the length of the work stroke and continuing the oscillating movement after this. The oscillating device includes a double-acting operating cylinder (1), a principal operating valve (6) controlling this, and a reversing valve (4), by which the principal operating valve (6) is controlled. A resistance to the flow on whichever return line (1.31, 1.41) of the operating cylinder (1) is in use, is arranged in order to maintain the return side pressure of the operating cylinder (1) at a level that is clearly higher than the ambient pressure during a work stroke in a normal situation, and sensing the pressure of the return side and, if it drops below a set limit, which is indicated by the movement of the pressure slowing or stopping completely, giving a command to the reversing valve (4) to change direction on the basis of this.
Patent AU-5896196-A (AU)
Title: Cobalt metal agglomerates, process for their production and their use
Inventor: GORGE ASTRID
IPC: B22F9/20
Filed: 1996-05-14
Abstract: PCT No. PCT/EP96/02053 Sec. 371 Date Apr. 24, 1998 Sec. 102(e) Date Apr. 24, 1998 PCT Filed May 14, 1996 PCT Pub. No. WO96/37325 PCT Pub. Date Nov. 28, 1996The present invention relates to cobalt metal agglomerates consisting of peanut-shaped primary particles with average particle sizes in the range from 0.5 to 2  mu m, to a process for the production thereof and to the use thereof.
Patent AU-5965394-A (AU)
Title: Textured, porous, expanded ptfe
Inventor: KOWLIGI RAJAGOPAL R
IPC: B29C48/00
Filed: 1994-01-12
Abstract: A more porous PTFE is obtained by impressing a pattern into extruded PTFE and then expanding the PTFE. The pattern can be impressed by knurling or, preferably, by rolling the sheet between the rollers having a pseudo-random pattern formed on the surface of the roller. The uniformity of the pores is controlled by the pattern: viz. a coarse pattern produces a wider distribution of internodal distances than a finer pattern. <IMAGE>
Patent AU-6088790-A (AU)
Title: Weed exterminator
Inventor: STEINEL HEINRICH W
IPC: A01M21/04
Filed: 1990-08-10
Abstract: The invention indicates a weed killer, in which the emerging hot air is generated by an electrically heated blower (4) and a fuel (15) such as e.g. brown coal, charcoal or hard coal. The device for generating the hot air flow comprises a fuel reservoir (6) and a hot air duct (7) which come together in a combustion chamber (8) which has an outlet opening (16) for the outlet of the hot air flow. The fuel reservoir (6) has in the transition to the combustion chamber (8) a fuel retention device (14), with which the fuel (15) is held in such a manner that a part of the fuel (15) lies in the combustion chamber (8) and in the hot air flow of the electrically heated blower (4). The hot air duct (7) is connected to the blower (4) so that, when the fuel (15) is blown onto with the hot air, the fuel ignites and hot air is thus produced which has a considerably higher temperature. <IMAGE>
Patent AU-6102494-A (AU)
Title: Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy
Inventor: CODINGTON JOHN F
IPC: G01N33/68
Filed: 1994-02-07
Abstract: A glycoprotein antigen which is generally characteristic of human carcinomas, regardless of the tissue associated with the carcinoma-human carcinoma antigen (HCA)-and which is generally not present on normal human cells. Immunodeterminant-containing fragments of HCA substantially separated from elements of HCA's naturally occurring environment are also disclosed. HCA is generally characterized by: a) a molecular weight in excess of 750,000; b) carbohydrate moieties characteristic of mucin-type glycoproteins and comprising a relatively high proportion of sialic acid, galactose, and N-acetylgalactosamine residues (e.g., at least 50% of the carbohydrate residues are sialic acid, galactose, or N-acetylgalactosamine residues); c) an isoelectric point below pH 3.0; d) presence generally on human carcinoma cells; e) absence generally from non-transformed human cells; f) at least one immunodeterminant that specifically reacts with anti-murine epiglycanin antibody AE3; and g) general insolubility in aqueous fluids (e.g., a phosphoric acid or an HCl solution) below pH 2.0. Also disclosed are antibodies to HCA, immunoassays for HCA and in vivo imaging using HCA-binding antibodies.
Patent AU-6193498-A (AU)
Title: Isoxazole derivatives
Inventor: NAKATSUKA MASASHI
IPC: C07D413/14
Filed: 1998-04-17
Abstract: An isoxazole derivative represented by formula (1): [wherein D is a hydrogen atom, a halogen atom, a hydroxyl group or the like; one of A and B is a group represented by formula (a): (wherein E is a single bond or an alkylene group, one of the two broken lines represents a double bond together with the solid line, while the other represents a single bond together with the other solid line. R<1> is bonded to the nitrogen atom bonded through the single bond represented by the broken line and the solid line, and R<1>, R<2>, R<3> and R<4> are independently a hydrogen atom, a halogen atom, a hydroxyl group or the like); and the other of A and B is a group represented by the formula: -J-G (wherein G is a substituted or unsubstituted aryl group or the like, and J is -C(R<8>R<9>)- or -C(=CR<8>R<9>)- (wherein R<8> and R<9> are independently a hydrogen atom, a substituted or unsubstituted lower alkoxy group, or the like))] or a pharmaceutically acceptable salt thereof is useful as, for example, a therapeutic drug for autoimmune diseases, inflammatory diseases, etc.
Patent AU-6195398-A (AU)
Title: HLA binding peptides and their uses
Inventor: KUBO RALPH T
IPC: A61P35/00
Filed: 1998-04-16
Abstract: The present invention provides peptide compositions capable of specifically binding selected MHC alleles and inducting T cell activation in T cells restricted by the MHC allele. The peptides are useful to elicit an immune response against a desired antigen.
Patent AU-6199190-A (AU)
Title: Novel entities for cancer therapy
Inventor: HUBER BRIAN
IPC: C12N9/12
Filed: 1990-08-29
Abstract: Novel molecular chimaeras produced by recombinant DNA techniques are described. They comprise a target tissue specific transcriptional regulatory sequence (TRS) linked and controlling the expression of a heterologous enzyme for example Varicella Zoster Virus Thymidine Kinase (VZV TK) gene. A molecular chimaera is packaged into a synthetic retroviral particle which is capable of infecting mammalian tissue. This in turn may be administered to a patient, and the TRS will be selectively transcriptionally activated in the target tissue (for example cancerous tissue). Administration of compounds which are selectively metabolised by the enzyme produce cytotoxic or cytostatic metabolites insitu thereby selectively killing or arresting the growth of the target cell.
Patent AU-6234594-A (AU)
Title: Functional domains in (flavobacterium okeanokoites) (foki) restriction endonuclease
Inventor: CHANDRASEGARAN SRINIVASAN
IPC: C12Q1/6827
Filed: 1994-02-10
Abstract: The present inventors have identified the recognition and cleavage domains of the FokI restriction endonuclease. Accordingly, the present invention relates to the DNA segments encoding the recognition and cleavage domains of Fok I restriction endonuclease, respectively. The 41 kDa N-terminal fragment constitutes the FokI recognition domain while the 25 kDa C-terminal fragment constitutes the FokI cleavage nuclease domain. The present invention also relates to hybrid restriction enzymes comprising the nuclease domain of the FokI restriction endonuclease linked to a recognition domain of another enzyme. Additionally, the present invention relates to the construction of two insertion mutants of FokI endonuclease.
Patent AU-6365990-A (AU)
Title: Composition, device and method of assaying for a peroxidatively active substance
IPC: G01N33/50
Filed: 1990-09-28
Abstract: A new and improved test device and method of determining the presence or concentration of a peroxidatively active substance, such as hemoglobin, in a test sample are disclosed. The test device includes a test pad comprising a suitable carrier matrix incorporating an indicator reagent composition capable of interacting with a peroxidatively active substance to produce a detectable or measurable response. In addition, a new and improved indicator reagent composition, comprising an indicator dye, such as a redox indicator, like a benzidine indicator; a hydroperoxide; an amine borate compound having the general structural formula: <CHEM> wherein R1, R2, and R3 are, independently, methyl groups or ethyl groups, and m, n and p are numerals ranging from one to about three; and a buffer, is incorporated into a suitable carrier matrix to provide a more accurate and trustworthy assay of a test sample for a peroxidatively active substance. The improved method and composition are especially useful in the assay of urine for occult blood.
Patent AU-6419190-A (AU)
Title: Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists
Inventor: HELLSTRAND JAN KRISTOFFER
IPC: A61K45/06
Filed: 1990-09-19
Abstract: A method of inhibiting the development of malignant tumors and the formation of metastases of malignant tumor cells in a subject carrying the comprises administering to the subject IL-2 and an agent selected from the group consisting of histamine, a histamine structural analogs having H2-receptor activities, an endogenous histamine releasing preparation, and a non-histamine derivative H2-receptor agonist; the agent and the IL-2 being administered in amounts and for a time effective to attain the desired effect. A method of increasing the anti-tumor cell effect of IL-2 in a subject comprises co-administering to the subject IL-2 and an agent such as histamine, histamine structural analogs having H2-receptor activities, endogenous histamine releasing preparations or H2-receptor agonists, the agent and the IL-2 being administered in anti-tumor effective amounts and for a period of time effective to attain the desired effect.
Patent AU-6430296-A (AU)
Title: Crosslinkable mixtures, a method of preparing them and their use
IPC: C08L83/04
Filed: 1996-08-27
Abstract: The crosslinkable compsn. opt. also contg. water or anorganic solvent and useful in coatings comprises: (a) a polysiloxane offering at least two olefinic or acetylenic unsatd. bonds; (b) a polyhydrogen-siloxane offering at least two directly Si-bonded H atoms; (c) a hydrosilylation catalyst (pref. a Pt cpd. or complex or elemental Pt on a carrier); (d) an inhibitor; (e) a P cpd. of formula PR3 where R = H, 1-18C alkyl, 6-30C aryl, 7-31C alkaryl or OR<1> (where R<1> = as for R excluding H) and each of the aryl gps. can be alkyl-substd.; and opt. also (f) further auxiliaries.
Patent AU-6461500-A (AU)
Title: Process for producing fine medicinal substances
Inventor: BEGON DOMINIQUE
IPC: A61K9/14
Filed: 2000-08-18
Abstract: A method of producing fine medicament particles suitable for inhalation, particles produced by the method and apparatus suitable for carrying out the method. The method comprises contacting a stream or streams of a solution of medicament with a stream or streams of a liquid in which the medicament is insoluble in a confined chamber such that a region of intense turbulence and mixing is formed. The medicament crystallises as fine particles with minimal inclusion of solvent or anti-solvent impurities. The crystallised medicament is separated from suspension by standard techniques. Careful control of relative stream velocity, solution concentration and proportion of solution and anti-solvent in the streams ensures a uniform product.
Patent AU-6467399-A (AU)
Title: Method for producing prosthetic moulded parts for dental use and prosthetic moulded part
Inventor: RUBEL SUSANNE
IPC: A61C13/00
Filed: 1999-09-30
Abstract: Metal such as gold or other precious metal is precipitated electrolytically using a pulsed current. Precipitation is normally completed within a period of 1 to 2 hours. A bath of aqueous gold sulfite is generally used.
Patent AU-6488294-A (AU)
Title: Hypoglycemic agents
Inventor: CULLINAN GEORGE JOSEPH
IPC: A61P3/10
Filed: 1994-06-22
Abstract: The present invention provides a method for treating hyperglycemia in mammals by administering an antiestrogen compound, selected from 1) triarylethylenes; 2) 2,3-diaryl-2H-1-benzopyrans; 3) 1-aminoalkyl-2-phenylindoles; 4) 2-phenyl-3-aroylbenzothiophenes; 5) 1-substituted-2-aryl-dihydronaphthalenes; and 6) benzofurans and pharmaceutically acceptable salts and solvates thereof.
Patent AU-6597181-A (AU)
Title: Elastomers
Inventor: STINGER H J
IPC: C08L67/02
Filed: 1981-01-05
Abstract: Conductive elastomeric compositions consisting essentially of a blend of a copolyetherester having 45-85 weight percent of long chains and 15-55 weight percent of short chains and melting at at least 90 DEG C. with a conductive filler consisting of carbon black or a mixture of carbon black with graphite, the resistivity of such compositions being less than about 2 ohm.cm can be fabricated or cast into thin, self-supporting films or sheets. Articles made from these compositions find utility in electrical and electronic equipment, business machines, and in applications where good aging properties are important.
Patent AU-6615298-A (AU)
Title: Device for distributing an oil-air mixture to different lubrication ducts of a machine housing
Inventor: REBS ALEXANDER SEN
IPC: B21B31/07
Filed: 1998-01-23
Abstract: The invention relates to a device positioned in a bore hole (10) of a machine housing, which device distributes an oil-air mixture to different lubricating ducts of the machine housing. Said device comprises at least one cylinder-shaped distributor (1) which is sealed off in relation to the wall of the bore hole along at least one of its faces (8) by means of a sealing ring (7) and whose axial position in the bore hole (10) is determined by at least one spacer element (2). The distributor (1) and spacer element (2) can both be inserted individually into the hole (10). A device designed in this way can be made easier to assemble by simple means. To this end, the invention provides for the distributor (1) and/or the spacer element (2) to have a step (4) embodied on their faces (2a), the diameter (d) of which is adjusted to the diameter of the sealing ring (7) in such a way that the external diameter of the sealing ring (7) is smaller than the internal diameter of the hole (10) when it is placed onto the step (4), and that said step (4) can be introduced into a recess (9), which is embodied in the face (8) of a distributor (1) or spacer element (2) assigned to the corresponding face (2a) of a corresponding distributor (1) or spacer element (2) and the diameter of which is at most equal to the diameter (d) of the step (4).
Patent AU-6984600-A (AU)
Title: 5-aminoalkyl and 5-aminocarbonyl substituted indoles
Inventor: ANDERSEN KIM
IPC: A61P9/12
Filed: 2000-09-08
Abstract: The present invention relates to 5-aminoalkyl and 5-aminocarbonyl substituted indole derivatives having formula (1), wherein R<1 >is-(CH2)n-1-CONR<10>R<11>, -(CH2)n-CONR<10>R<11 >or (a), wherein R<10 >and R<11 >independently are selected from substituents defined herein; n is 1 to 3 and q is 2 to 5; G is N, C, or CH; Ar is phenyl optionally substituted with one or more substituents, or Ar is heterocyclic; R<2>, R<3>, R<4>, R<5 >and R<6 >are independently selected from substituents defined herein; m is an integer from 2-6; W is O or S; U is N or CH; Z is -(CH2)p-, p being 2 or 3, or Z is -CH=CH-or 1 ,2-phenylene, or Z is-COCH2- or -CSCH2-; V is O, S, CH2, or NR<9>; X is N, C, or CH; Y is N, C, or CH; provided at least one of X and Y is N; or a pharmaceutically acceptable acid addition salt thereof. The novel 5-substituted indoles have high affinity for alpha1-adrenoceptors and are considered useful for the treatment of diseases or disorders responsive to alpha1-adrenoceptor antagonists. Further, as the compounds are selective alpha1-adrenoceptor ligands they may be particularly useful as PET or SPECT ligands.
Patent AU-7114491-A (AU)
Title: Sealless modular dispenser
Inventor: BREAULT JOHN P
IPC: F16K21/16
Filed: 1991-02-18
Abstract: Modular apparatus for dispensing precise quantities of a fluid product including a dispensing unit (22) and an actuator unit (26). A housing (30) of the dispensing unit (22) defines a reservoir (36) which contains the product under pressure. Within the housing is a ball-type valve mechanism. A deformable diaphragm (50) isolates the reservoir (36) from the mechansim which actuates the valve to prevent undesirable entry of the product. The diaphragm (50) may be of a number of shapes, depending upon the length of the stroke desired for the ball mechanism. The dispensing unit (22) is readily removable from the actuator unit (26) and can be readily replaced with another dispensing unit. Different nozzle sizes can also be accommodated. The extent of the valve opening is adjustable in discrete increments.
Patent AU-7350791-A (AU)
Title: Process for preparation of fluoromethyl-substituted pyridine dicarboxylates
Inventor: MILLER WILLIAM HAROLD
IPC: C07B61/00
Filed: 1991-03-18
Abstract: Described herein is a process for preparation of 5 substituted pyridine dicarboxylate compounds.
Patent AU-7447194-A (AU)
Title: Higher purity imidazoline based amphoacetate surfactants and processes for the preparation thereof
Inventor: DESAI BHARAT
IPC: C09K23/00
Filed: 1994-10-06
Abstract: Surfactant composition comprising an amphoacetate (I) derived from a substituted imidazoline contains less than 3.5% nonalkylated amide, less than 4.5% glycolic acid and less than 27 % alkali metal halide. Surfactant composition comprising an amphoacetate of formula (I) derived from a substituted imidazoline contains less than 3.5% nonalkylated amide, less than 4.5 % glycolic acid and less than 27 % alkali metal halide. R-CO-NH-CH 2CH 2-N((CH 2) nX)-CH 2COOM (I) R : 5-19C aliphatic group; n : 2-4; X : OH or NH 2; M : a metal.
Patent AU-7504598-A (AU)
Title: Oligonucleotides for detecting lactic acid bacteria and a new method for judging by utilizing them
Inventor: SAMI MANABU
IPC: C12Q1/68
Filed: 1998-07-07
Abstract: The present invention provides a method for confirming the presence or absence of a gene resistant to hop, which is a most important factor for determining beer-spoilage ability of lactic acid bacteria, and for foreseeing rapidly the beer-spoilage of lactic acid bacteria, by using particular oligonucleotides and a judgement method utilizing them.
Patent AU-7754291-A (AU)
Title: Process for the coating of electrically conductive substratesand cathodically depositable aqueous electrocoating paint
Inventor: RUHL DIETER
IPC: C09C1/28
Filed: 1991-04-25
Abstract: PCT No. PCT/EP91/00803 Sec. 371 Date Jan. 11, 1993 Sec. 102(e) Date Jan. 11, 1993 PCT Filed Apr. 25, 1991 PCT Pub. No. WO91/18063 PCT Pub. Date Nov. 28, 1991.The invention relates to aqueous electrocoating paints which contain 2 to 10% by weight of an anticorrosive pigment based on zinc silicate in combination with 1 to 15% by weight of a very fine quartz powder or cristobalite powder coated with epoxysilane or aminosilane, the percentages by weight being based on the total solids content of the electrocoating paint and the anticorrosive pigment being preparable by fusing together 35 to 65% by weight of ZnO, 15 to 35% by weight of SiO2 and 0 to 20% by weight of B2O3 and/or 0 to 20% by weight of WO3 and/or 0 to 20% by weight of MoO3 and/or 0 to 20% by weight of SnO2, the components being fused together using at least one of the cited oxides besides ZnO and SiO2 in such a manner that the percentages by weight always total 100.
Patent AU-8127398-A (AU)
Title: Polyol-amino acid compounds having anti-(helicobacter pylori) activity
Inventor: MIYAGAWA KEN-ICHIRO
IPC: C07D207/16
Filed: 1998-07-08
Abstract: A compound of the formula (I):wherein R1 represents an amino group which may be substituted; R2 represents a carboxy group which may be esterified or amidated; R3, R4, R5 and R6 each represent a hydroxy group which may be protected; Q represents an aryl group which may be substituted; or a salt thereof is disclosed. The compound (I) possesses ant-Helicobacter pylori activity, and is useful in the prevention or treatment of various diseases associated with Helicobacter bacteria, such as duodenal ulcer, gastric ulcer, chronic gastritis and cancer of the stomach.